1. endocrinology part 1
TRANSCRIPT
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 1/131
Endocrinology part 1: Adrenal glands
Marcin Adamczak
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 2/131
• Adrenal glands physiology,
• Adrenal cortex diseases,
Cushing’s syndrome
Mineralocorticoid excess
Adrenal insufficiency
Congenital adrenal hyperplasia
•
Adrenal medulla diseases, Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 3/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 4/131
paired glands located retroperitoneally at the
upper pole of each kidney
Adrenal glands:
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 5/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 6/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 7/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 8/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 9/131
Adrenals: Cross section Cortex = yellow
Medulla= red to grey
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 10/131
Adrenal gland: Cross section
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 11/131
Adrenal glands:
include two distinct endocrine organs:inner medulla part of sympathetic nervous
system, secretes catecholamines,
outer cortex – sectretes numerous of different
steroid hormones;
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 12/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 13/131
Zona: reticularis, fasciculata, glomerulosa
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 14/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 15/131
CH3
CH3
O
O
OHOHOH
Hydrocortisone(11!,17",21-trihydroxy-
pregn-4-ene-3,20-dione) !
CH3
O
O
OHOH
CHO
Aldosterone(11!,21-dihydroxy-
pregn-4-ene-3,18,20-trione) !
Adrenocorticoids
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 16/131
Hypothalamic-pituitary-adrenal axis
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 17/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 18/131
Pituitary - ACTH
•
39 AA; active 1-24 N-terminal fragment
• proopiomelanocortin precursor (ACTH andmelanotropins, lipotropins and B-endorphin) !
•
circadian rhythm peaks in the morning•
Stimulus: CRF - stress, hypoglycemia,
•
CRF-feedback from glucocorticoids in circulation
•
action- adrenal cortex secrete glucocorticoids,lesser aldosterone
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 19/131
Rate Limiting Step•
ACTH stimulated
• Mitochondrial step
• 2 hydroxylations
• side chain cleavage
•
P450SCC( cholestrol 20,22-hydroxylase;
•
20-22 desmolase activity) !
Activation of Pathway=• Increased cholesterol utilisation
• Cholesterol ester ==> free Cholesterol
#
$
Cholesterol synthesis
#
$
Cholesterol uptake by adrenals
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 20/131
P450 C21 hydroxylase
(microsomal) !
11ß-hydroxylase
(mitochondrial) !
CORTISOL
18 hydroxylaseoccur in zona glomerulosa only
18-OH steroid dehydrogenase
ALDOSTERONE
Androgens17
hydroxylase
17,20 desmolase
does not occur in
zona glomerulosa
DHEA &Androstendione
substrate for other
tissues
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 21/131
Adrenocorticoids
Biological Activities1. Glucocorticoid Activity
1.1 Effects on Metabolism1.1.1 Stimulation of gluconeogenesis, particularly in the liver
1.1.2 Mobilization of amino acids from extrahepatic tissues
1.1.3 Inhibition of glucose uptake in muscle and adipose tissue
1.1.4 Stimulation of fat breakdown in adipose tissue
1.2 Effects on Inflammation and Immune Function
1.2.1 Anti-inflammatory properties
1.2.2 Immunosuppressive properties
1.3 Other Effects of Glucocorticoids1.3.1 Multiple effects on fetal development (promote maturation of the lung) !
1.3.2 Miscellaneous effects (Excessive glucocorticoid levels affect many
systems, e.g., inhibition of bone formation, suppression of calcium
absorption and delayed wound healing.) !
2. Mineralocorticoid Activity
2.1 Effect on Electrolytes
2.1.1 Increased re-absorption of sodium2.1.2 Increased renal excretion of potassium
2.2 Effect on Water
2.2.1 Increased re-absorption of water
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 22/131
CORTISOL
reduce APC formation
of certain cytokines(IL-1, IL-6, TNF) !
reduce lymphocyte gene
activation for cytokine
synthesis
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 23/131
ACTH 15-70 pg/ml
Cortisol 5-25 µg%circadian rhythm peaks in the morning (6-8 am) the lowest plasmaconcentration about midnight (60% lower) !
Free cortisol in 24 h urine 50-125 µg/24h
17 hydroksycorticosteroid in 24 h urine 3-16 mg/24h (female) and 6-26 mg/24h (male)
Aldosteron 2-15 ng%
Aldosteron in 24 h urine 5-10 µg/24h
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 24/131
• Adrenal glands physiology,
•
Adrenal cortex diseases,
Cushing’s syndrome
Mineralocorticoid excess
Adrenal insufficiency
Congenital adrenal hyperplasia
•
Adrenal medulla diseases, Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 25/131
Adrenal Cortex Disease
•
Clinical manifestations result from:- – Overproduction or deficiency of:
•
Glucocorticoids
• Mineralocorticoids
•
Androgens
•
Hyper-secretion may presentdifferently depending on the disease
mechanism.
•
Hypo-secretion may only be apparentat times of stress.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 26/131
• Adrenal glands physiology,
•
Adrenal cortex diseases,
Cushing’s syndrome
Mineralocorticoid excess
Adrenal insufficiency
Congenital adrenal hyperplasia
•
Adrenal medulla diseases, Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 27/131
Cushing’s syndrome – refers to the
manifestation of glucocorticoids excess from any
cause (nonspecific designation).
Cushing’s disease – excess production of
ACTH by pituitary gland causing manifestation of
adrenal hypercortisolism.
Overproduction of Glucocorticoids
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 28/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 29/131
Cushing’s syndrome - causes:
-
Cushing’s disease – 80%- Adrenal neoplasm (adenomas or carcinomas) –
10-15%
- Ectopic ACTH-producting tumor –
5-10%- Bilateral adrenal hyperplasia with undetectable ACTH – less than 1%
- Iatrogenic Cushing syndrome
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 30/131
Cushing syndrome
ACTH
dependent independent
ACTHACTH
Cortisol
ACTH ACTH
Adenoma Carcinoma
70% 12% 10% 8%
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 31/131
Hypothalamic-pituitary-etiology(Cushing’s disease).
Stress Diurnal rhythm
CRH
ACTH
Cortisol
Hypothalamus
Pituitary
Adrenal glands
?
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 32/131
Cushing’s disease:
- 90% - pituitary adenoma, 10% pituitary
hyperplasia,
- usually basophilic microadenoma,
- bilateral adrenal hyperplasia is due to increased
pituitary secretion of ACTH,
-
more frequently in women than men (female-male ratio 5:1); usually occurs during thechildbearing age,
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 33/131
A
B
C
A= Addsion’s disease or long term corticosteroids
B= Normal
C= ACTH excess: Cushing’s disease or ectopic.
Idiopathic adrenal hyperplasia
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 34/131
Ectopic ACTH syndrome .Stress Diurnal rhythm
CRH
ACTH
Cortisol
Hypothalamus
Pituitary
Adrenal glands
?
Tumor ACTH
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 35/131
Ectopic ACTH syndrome:
- Ectopic ACTH-production by tumours such as oat cell
carcinoma of the lung, carcinoma of the pancreas,bronchial adenoma and others causes adrenalhyperplasia.
- more frequent in men than in women (older age),
-
In addition to increase of cortisol plasma level suchpatients may have greatly increase level ofdeoxycorticosterone (DOC) a potent mineralocorticoid.That can result in severe hypertension, hypokalemia andmetabolic alkalosis.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 36/131
Primary adrenal neoplasm
Stress Diurnal rhythm
CRH
ACTH
Cortisol
Hypothalamus
Pituitary
Adrenal glands
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 37/131
Primary adrenal neoplasm:
- adenomas or carcinomas,
- Carcinomas are the most frequent spontaneusCushing’s syndrome in children.
- Carcinomas are usually large (> 6 cm).
- Adenomas secrete mainly cortisol. Carcinomas
produces usually variety of adrenal hormones(glucocorticoids, mineralocorticoids, androgensand estrogens).
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 38/131
Adrenal gland removed surgically in a patient with Cushing'ssyndrome - adenoma. Some remaining atrophic adrenal is seen
at the right. Histologically, it is composed of well-differentiated
cells resembling cortical fasciculata zone. It is benign.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 39/131
This is a large adrenal cortical
carcinoma which is displacing
the left kidney downward. Such
neoplasms are usually functional
(secreting corticosteroids or sex
steroids). They have a poor
prognosis.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 40/131
Cushing’s syndrome-
symptoms (1):
- Central obesity –caused by effect of cortisolon fat distribution. Fataccumulates in the face,neck, trunk, while thelimbs remain thin. ” Themoon face”, ”Buffalohump” (cervical fat pad),supraclavicular fat pads.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 41/131
Cushing’s syndrome- symptoms (1):
” The moon face”,”Buffalo hump” (cervical fat pad),
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 42/131
Moon face; florid complexion (red face) !
Cushing’s syndrome- symptoms (1):
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 43/131
Cushing’s syndrome- symptoms (2):
2) Hypertension
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 44/131
Cushing’s syndrome- symptoms (2):
2) caused by increase cortisol-induced gluconeogenesisand decreased peripheral glucose utilization; 20% ofpatients have overt diabetes mellitus.
4) Symptoms of androgen excess (oligomenorrhea,hirsutism and acne); in women with Cushing’s disease
stimultion of androgen secretion by ACTH,
5) Purplae striae – linear marks on the abdomen wherethe thin and wasted skin is stretched by underlying fat,
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 45/131
Purplae striae – linear marks on the abdomen
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 46/131
Purplae striae
Moon face
Central obesity
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 47/131
Cushing’s syndrome- symptoms (3):
6) Muscle wasting and weakness – caused bycatabolic effects of cortisol on muscle protein.
7) Osteoporosis – caused by cortisol’s effects onincreased bone catabolism and inhibitory effects oncollagen synthesis and calcium absorption,
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 48/131
Osteoporosis
Cushing’s syndrome
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 49/131
Cushing’s syndrome-
symptoms (3):
8) Susceptibility to bruising –probably caused by enhanced
capillary fragility,
9) Psychiatric disturbances –especially depression.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 50/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 51/131
Cushing’s syndrome- diagnosis (1):
The diagnostic approach in patients who aresuspected of having Cushing’s syndromeconsists of two phases.
1) Does the patients have Cushing’s syndrome?
2) If Cushing’s syndrome is present what is itscause?
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 52/131
Cushing’s syndrome- diagnosis (2):Does the patients have Cushing’s syndrome?
1)
exclusion exogenous cause of Cushing’s syndrome bythe medical history,
2) high urine free-cortisol excretion rate,
3) ”low-dose dexametasone test”
- 1 mg dexametasone orally between 11-12 p.m.,
- measure plasma cortisol level 8 a.m.
plasma cortisol < than 5 g/dl - normal supression,
> than 5 g/dl – Cushing’s syndrome,
needs further study.
This test is sensitive but is not very specific – mental and physical
stress may produce a false positive results
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 53/131
Cushing’s syndrome- diagnosis (3):
What is the cause of Cushing’s syndrome?
1)
”standard high-dose dexametasone test”
The suppressibility of hypothalamic-pituitary-adrenalaxis is tested by the administration of dexamethasonein high doses. Patients with Cushing’s disease behave as
though their feedback response to glucocoticoid isintact but set a higher than normal level. They respondto high but not to low doses of dexamethasone. Patientswith adrenal tumors and ectopic ACTH secretionproduce corticoid autonomously, without suppression
even by high doses of dexamethasone.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 54/131
Cushing’s syndrome- diagnosis (4):
What is the cause of Cushing’s syndrome?
1) ”standard high-dose dexametasone test” c.d.
- 8 mg (2 mg 4 times daily) dexametasone daily orallyduring 2 days,
- measure plasma cortisol level, urinary free cortisol
and urinary 17-hydroxycorticosteroid exctretion rate,
before and in a second day of dexametazone
treatment.
healthy subjects – suppression (decrease > 50 %),
Cushing’s disease - suppression (decrease > 50 %),
adrenal neoplasm – no suppression,
ectopic ACTH syndrome – no supression.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 55/131
Cushing’s syndrome- diagnosis (5):
What is the cause of Cushing’s syndrome?
2) Plasma ACTH levelCushing’s disease – high normal or slightly elevated,
ectopic ACTH – markedly elevated,
adrenal neoplasm – extremely low or undetectable.
3) Radiographic finding – localize the primaryabnormality and confirm etiological diagnosis.
- skull X-ray (enlargement of sella turcica – in case of
macroadenomas),
- MRI or computed tomography of pituitary,- ultrasonography, MRI or computed tomography of
adrenal glands.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 56/131
Petrosal sinus sampling : Pituitary orectopic?
•
Ratio Petrosal/peripheral
ACTH >2:1 if pituitary.
•
Lateralisation ofmicroadenoma : -
– Localisation of microadenoma.
– Ipsilateral ACTH release
of ACTH by adenoma
•
Pituitary not hypothalamicvia CRF:-
– Both sides high ACTH if
CRH secreting tumour
Cushing’s syndrome- diagnosis (6):
What is the cause of Cushing’s syndrome?
JUGULAR VEIN
Confluent
Pituitary
Veins
Cavernous
Sinus
Inferior Petrosal
Sinus
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 57/131
• Adrenal glands physiology,
•
Adrenal cortex diseases,
Cushing’s syndrome
Mineralocorticoid excess
Adrenal insufficiencyCongenital adrenal hyperplasia
•
Adrenal medulla diseases, Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 58/131
P450 C21 hydroxylase
(microsomal) !
11ß-hydroxylase
(mitochondrial) !
CORTISOL
18 hydroxylase
18-OH steroid dehydrogenase
ALDOSTERONE
Androgens17
hydroxylase
17,20 desmolase
does not occur in
zona glomerulosa
DHEA &Androstendione
substrate for other
tissues
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 59/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 60/131
The renin-angiotensin-aldosterone system
Serum K +
AldosteroneDistal
nephronH+
excretion
K +
excretion
NaCl
reabsorptionEffective
ECF volume
ACTH
BP
Renin AI AII –
–
–
Di t l l t d t b l ll
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 61/131
CYTOPLASM
K +
Na+
ADP + Pi
Pump
K +
ATP
Na
+
Permease
hypothesis
Na+
Distal convoluted tubule cell
Aldosterone
from blood
diffusion
into cell
Apical
membraneBasolateral
membrane
I n t e r s t i t i
um
Nucleus
Induced gene
HREmRNA
Aldosterone-
induced
proteins
cytoplasmic mineralocorticoid receptor (MR) !
homodimeric steroid-
receptor complex
Mitochondrium
Met abolic
hypothesis
T u b u l a r
l u m e n
Na+ pump
hypothesis
Na+ Na+Na+
Na+
K +,H+
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 62/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 63/131
Mineralocorticoid Excess (1) !
•
Primary hyperaldosteronism
(overproduction of aldosterone independent of it’snormal chronic regulator Angiotensin 2)
•
Secondary hyperaldosteronism (overproduction of aldosterone dependent of it’snormal chronic regulator Angiotensin 2)
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 64/131
•
Adenoma (50-90%) !
•
Bilateral Adrenalcortical Hyperplasia(10%).
•
Sporadic or Familialhyperaldosteronism(Type FH2).
• ACTH dependantrelease
(dexamethasonesuppressible FH1).
Primary hyperaldosteronism
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 65/131
Mineralocorticoid Excess (2) !
Primary hyperaldosteronism
Diagnostic features:
1) High Aldosterone
2) Low Plasma Renin3) High Aldosterone/Plasma Renin Ratio
Mi l ti id E (3) !
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 66/131
Mineralocorticoid Excess (3) !
Primary hyperaldosteronism:
Conn's syndrome (adrenal adenoma producing aldosterone)- Conn's syndrome (50 - 90% of cases) ishyperaldosteronism due to functional adenoma . The
normal feedback loops are intact so the renin is low. It
most commonly occurs from age 30-50 years andpresents as hypertension. It accounts for less than 1% ofhypertensive patients. In several of patients signs of renal disease (50% develop proteinuria, 15% develop renal
failure).
Laboratory findings include low potassium and highsodium serum concentration.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 67/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 68/131
1.3 cm left adrenal adenoma in a patient with hypertension and
hypokalemia. Such adenomas are typically less than 2 cm in size and
yellow on cut surface.
Conn's syndrome (adrenal adenoma producing aldosterone) !
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 69/131
Mineralocorticoid Excess (4) !
Secondary hyperaldosteronism: -
–
Renal artery stenosis,
– Renin secreting tumours,
–
Barters syndrome, –
Diuretic and/or laxative abuse.
Diagnostic features:
1) High Aldosterone2) High or Inappropriate Plasma Renin
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 70/131
Mineralocorticoid Excess (5) !
Biochemical diagnosis•
Primary hyperaldosteronism: -
– Raised/Normal plasma aldosteroneconcentration
–
Suppressed/low PRA – High plasma aldosterone concentration/
PRA ratio.
• Secondary hyperaldosteronism: -
–
Raised plasma aldosterone concentration
– Raised or “normal” (inappropriate) PRA.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 71/131
Mineralocorticoid Excess (5) !
Biochemical diagnosis
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 72/131
• Adrenal glands physiology,
•
Adrenal cortex diseases,
Cushing’s syndrome
Mineralocorticoid excess
Adrenal insufficiencyCongenital adrenal hyperplasia
• Adrenal medulla diseases, Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 73/131
Primary adrenal insufficiency.
Stress Diurnal rhythm
CRH
ACTH
Cortisol
Hypothalamus
Pituitary
Adrenal glands
MSH
?
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 74/131
Secondary adrenal insufficiency.
Stress Diurnal rhythm
CRH
ACTH
Cortisol
Hypothalamus
Pituitary
Adrenal glands
Primary adrenal insufficiency (1):
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 75/131
Primary adrenal insufficiency (1):
- uncommon disorders, usually occured between ages 20and 50
- female:male incidence ratio 2.6:1
- clinical symptoms are caused mainly by both cortisol
and aldosterone deficiencies- clinical manifestations do not appear until at least 90%of cortex has been compromised
Primary adrenal insufficiency (2):
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 76/131
Primary adrenal insufficiency (2):
causes:
- autoimmune (Addison’s disease) (75%),
- tuberculosis (20%),
-
others (5%); among them hemochromatosis, amyloidosis, bilateral adrenal haemorrhage (in the Waterhouse-
Friederichsen syndrome or in patients during
anticoagulation), fungal and CMV infection in patients
with AIDS, metastatic malignancy, after bilateral
adrenadrelectomy, after aminoglutetymide treatment
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 77/131
A
B
C
A= Addsion’s disease or long term corticosteroidsB= Normal
C= ACTH excess: Cushing’s disease or ectopic.
Idiopathic adrenal hyperplasia
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 78/131
Caseating granuloma of tuberculosis in the
adrenal gland.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 79/131
Hemochromatosis in the adrenal gland.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 80/131
Amyloidosis in the adrenal gland.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 81/131
Primary adrenal insufficiency (3):
Symptoms of cortisol deficiency:
1) hyperpigmentation of skin - caused by $MSH,
2) hypotension (often orthostatic) - caused by absence ofcortisol’s pressor effect on vasculature and decrease ofcardiac output,
3) anorexia, nausea, vomiting, weight loss,
4) hypoglycaemia - %cortisol-induced gluconeogenesis,
5) mental symptoms – lethargy and confusion,
6) intolerance to stress – severe stress leads to exacerbation of
symptoms (patients can not to increase their steroid outputduring the stress).
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 82/131
Primary
adrenal
insufficiency
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 83/131
Primary adrenal insufficiency
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 84/131
Primary adrenal insufficiency (3):
Symptoms of cortisol deficiency:
1) hyperpigmentation of skin - caused by $MSH,
2) hypotension (often orthostatic) - caused by absence ofcortisol’s pressor effect on vasculature and decrease ofcardiac output,
3) weight loss, anorexia, nausea, vomiting, pain in theabdomen
4) hypoglycaemia - %cortisol-induced gluconeogenesis,
5) mental symptoms – lethargy and confusion,
6) intolerance to stress – severe stress leads to exacerbation ofsymptoms.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 85/131
Primary
adrenal
insufficiency
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 86/131
Primary adrenal insufficiency (4):
Symptoms of aldosterone deficiency:
1) sodium loss – volume depletion, hypotension,decrease of cardiac output, % RBF with renalinsufficiency, weight loss,
2) potassium retention – hyperkalemia and cardiacarrhythmias. women loss of axillary and pubic hair
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 87/131
Primary adrenal insufficiency (5):
Symptoms of androgens deficiency in females:
1) women loss of axillary and pubic hair
Clinical Features of Primary Adrenal
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 88/131
Clinical Features of Primary AdrenalInsufficiency
• Gradual onset >95%
• Weakness & fatigue 100%
•
Wt loss/anorexia 100%
•
Hyperpigmentation 92%•
Hypotension / tachycardia 88%
•
Hyponatremia 88%
•
Hyperkalemia 64%• Muscle, GI pain 56%
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 89/131
Primary adrenal insufficiency (6):
Diagnosis:
-
Plasma cortisol, urinary free cortisol, urinary 17-hydroxycorticosteroid are low (usually without circadianrhythm).
- Plasma ACTH is high ( >200 N:20-100 ng/ml) !
-
Hyponatremia, hyperkalemia, hypoglycemia, chest X-raymay revealed small heart.
- Short ACTH test: synacten (first 24 AA ACTH analog) 0.25mg i.v.or i.m.. Cortisol is measured before injectionand after 30minutes.
Normal response – at least 7 µg% increase in serumcortisol concentration ans should reach 18 µg%.
Lower response – adrenal hypofunction
Ald t d fi i ith t l ti id
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 90/131
Aldosterone deficiency without glucocorticoid
deficiency:
Cause:- deficient secretion of renin – hyporeninemic
hypoaldosteronism (e.g. autonomic insufficiency, -blocker therapy, injury of juxtoglomerular
apparatus),
-
primary abnormality of zona glomerulosa(autoimmune process, critically ill patients, ACEItherapy, corticosterone methyloxidase deficiency).
Clinical features:
-
usually asymptomatic,
- hyperkalemia.
H i i h ld t i
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 91/131
Hyporeninic hypoaldosteronism
Serum K +
Distal
nephron
H+
excretion
K +
excretion
or N
NaCl
reabsorption
or N
Effective
ECF volume
or N
BP
Renin # AI # AII # Aldosterone
P ima h poaldoste onism
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 92/131
Primary hypoaldosteronism
Serum K +
Aldosterone Distal
nephron
H+
excretion
K +
excretion
NaCl
reabsorption
Effective
ECF volume
BP
Renin AI AII
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 93/131
Secondary adrenal insufficiency.
Stress Diurnal rhythm
CRH
ACTH
Cortisol
Hypothalamus
Pituitary
Adrenal glands
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 94/131
Secondary adrenal insufficiency (1):
Causes:1) destructive lesions in the hypothalamic-pituitary axis,
2) isolated ACTH secretion defect,
3) prolonged suppression of pituitary-adrenal axis byexogenous glucocorticoids.
Secondary adrenal insufficiency (2):
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 95/131
Secondary adrenal insufficiency (2):
Clinical and diagnostic features:
Similar to those for primary glucocorticoid deficiency, butwith several important differences:
1) hyperpigmentation is absent (normal plasma MSHconcentration),
2) hyperkalemia and metabolic alkalosis did not occurred(normal mineralocorticoid level),
3) clinical manifestations of hypogonadism and hypothyreosisfrequently occurred (in case of primary pituitary disease).
Secondary adrenal insufficiency (3):
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 96/131
Secondary adrenal insufficiency (3):
Diagnosis:
Prolonged ACTH test:synacten depot i.m. 0,5 mg twice daily during 4 days
Normal response – three-five fold increase in urinarycortisol, urinary 17-hydroxycorticosteroid excretion rate;
a 15-40 g/dl rise in serum cortisol level.
Primary adrenal insufficiency: lower responseSecondary adrenal insufficiency: normal but later than in
haelthy subjects response (lack of response during first
and second day, stepwise increase or normal responseduring by the third or fourth day)
Clinical Features of Secondary Adrenal
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 97/131
Clinical Features of Secondary AdrenalInsufficiency
• Gradual onset >95%
•
Weakness & fatigue 100%
• Weight loss/anorexia 100%
•
Pale 100%
• Hair loss <50%
•
Anemia <50%
•
Electrolytes usually normal
Adrenal insufficiency treatment:
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 98/131
Adrenal insufficiency treatment:•
Glucocorticoid replacement is required in all patients
Daily dose: 37.5 mg cortisone or 30 mg hydrocortisone (2/3 of
dose in the morning) ! • Mineralocorticoid replacement is not required in all patients
Daily dose: Fludrocortison 0.05 – 0.2 mg in the morning
Stress, infection, surgery: dose of glucocorticoids shouldbe higher.
• 40-60 mg daily hydrocortisone during minor stress (e.g.
common cold or dental extraction) !
•
100 mg daily hydrocortisone during moderate stress (e.g.influenza or minor surgery) !
• 300 mg or more daily hydrocortisone during major stress
(e.g. severe infection or major surgery) !
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 99/131
Primary Acute Adrenocortical
InsufficiencyOccurs in a variety of clinical settings:
•
1) Addisonian “crisis” in patients with chronicadrenal insufficiency who are subject to stress
• 2) Rapid withdrawal of steroids in patients ontherapy or failure to supplement patients on therapy
during acute stress
•
3) Massive adrenal hemorrhage
Adrenal crisis (Addisonian crisis):
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 100/131
Adrenal crisis (Addisonian crisis):
Acute life-threating complication of Addison’s disease inwhich the manifestations of adrenal insufficiency are greatlyexaggerated. Adrenal crisis may occur in untreatedAddison’s disease or in a treated patient following acutestress if additional glucocorticoid replacement is notprovided.
Clinical features:
vascular collapse, shock (and as a consequence oliguria), low bodytemperature in the initial phase and fever in the late phase,vomiting, signs of dehydratation, abdominal pain
(pseudoperitonitis), altered mental status.
hypoglycemia, metabolic acidosis, hyperkalemia, hyponatremia(in 90% of cases), plasma sodium/potassium ratio < 30
Adrenal crisis (Addisonian crisis) treatment:
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 101/131
Adrenal crisis (Addisonian crisis) treatment:
•
NaCl and glucose i.v. infusion (up to 4 liters).• Hydrocortison i.v. 100 mg every 6 hours.
Ad l l d h i l
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 102/131
• Adrenal glands physiology,
•
Adrenal cortex diseases,
Cushing’s syndrome
Mineralocorticoid excess
Adrenal insufficiencyCongenital adrenal hyperplasia
• Adrenal medulla diseases, Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 103/131
Congenital adrenal hyperplasiaStress Diurnal rhythm
CRH
ACTH
Cortisol
Hypothalamus
Pituitary
Adrenal glands
?
Androgens
C i l d l h l i (1)
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 104/131
Congenital adrenal hyperplasia (1):
!
Caused by a defect in one of the enzymes that are necessaryto synthesized cortisol (21-hydroxylase, 11-hydroxylase, 17-hydroxylase deficiency, hydroxylase 3-steroid or 5,4Isomerase deficiency). Cortisol deficiency stimulates ACTHsecretion which, causes hyperplasia adrenal cortex and
overproduction of ACTH dependent steroids (mainlyandrogens).
! Clinical manifestations depend mainly upon androgensoversecretion (ambiguous genitalia or virilisation infemales, macrogenitosomia or precocious puberty inmales).
Congenital adrenal hyperplasia (2):
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 105/131
Congenital adrenal hyperplasia (2):
Diagnosis:! Low plasma cortisol and high plasma ACTH concentration
! High blood testosterone concentration
!
Increase of steroid specific to the enzyme abnormality
C it l d l h l i (2)
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 106/131
Congenital adrenal hyperplasia (2):
!
21-hydroxylase deficiency The most frequent syndrome (1:5000-1:15000 of newborn; 95% cases ofcongenital adrenal hyperplasia ). High 17-OH progesterone plasmaconcentration
! 11-hydroxylase deficiency
High 11-Deoxycorticosterone (DOC) and 11-Deoxycortisol plasmaconcentration
! 17-hydroxylase deficiency
Low plasma cortisol, estrogens and androgens concentrations, high 11-Deoxycorticosterone (DOC) (mineralocorticoid) plasma concentration.
!
hydroxylase 3-steroid or 5,4 Isomerase deficiency Low plasma cortisol, estrogens and androgens concentrations, high 17-OH
pregnenolone and dehydroepiandrosterone (DHEA) plasma concentration
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 107/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 108/131
21-Hydroxylase Deficiency
Three distinct syndromes are known:
1) “Classic”, salt-wasting adrenogenitalism related to 21-
hydroxylase deficiency presenting at birth with
virilization in females; cryptorchidism and hypospadias in
males; salt wasting is due to concomitant aldosterone
deficiency
2) A simple virilizing variant with normal aldosterone
activity
3) A “nonclassic” variant with delayed onset of virilization
during late childhood or adolescence
C it l d l h l i (2)
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 109/131
Congenital adrenal hyperplasia (2):
!
21-hydroxylase deficiency The most frequent syndrome (1:5000-1:15000 of newborn; 95% cases ofcongenital adrenal hyperplasia ). High 17-OH progesterone plasmaconcentration
! 11-hydroxylase deficiency
High 11-Deoxycorticosterone (DOC) and 11-Deoxycortisol plasmaconcentration
! 17-hydroxylase deficiency
Low plasma cortisol, estrogens and androgens concentrations, high 11-Deoxycorticosterone (DOC) (mineralocorticoid) plasma concentration.
!
hydroxylase 3-steroid or 5,4 Isomerase deficiency Low plasma cortisol, estrogens and androgens concentrations, high 17-OH
pregnenolone and dehydroepiandrosterone (DHEA) plasma concentration.
Review of congenital adrenal hyperplasia
syndromes caused by various defects in the
Cholesterol
StAR
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 110/131
Corticosterone (ZF/ZR) !
Aldosterone (ZG) !
Dehydroepiandrosterone(DHEA) ! 17"-OH pregnenolone
17 -hydroxylase
11
-Hydroxylase
Cortisol
11-Deoxycorticosterone (DOC) !
17"-OH progesterone
21-Hydroxylase
11-Deoxycortisol
Progesterone
3
-OHSD/&
5,4 Isomerase salt loss + female: virilized; male: hypogonadal
composite pathway of steroid hormone
biosynthesis .
P-450scc ACTH
Pregnenolone
Cholesterol
salt loss/sexual infantilism
Aldosterone synthase
Hypertension/sexual
infantilism
17
-hydroxylase
ALDOSTERONE
CORTISOLCORTICOSTERONE
salt loss/virilization
hypertension/virilization
initial salt loss
Testosterone
(made in peripheral
tissues by reduction of
androstenedione) !
Androstenedione
Congenital adrenal hyperplasia: 11- hydroxylase deficiency
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 111/131
prominent recession of the hairline characteristic of male baldness,and the patient also has dark hair on the upper lip and acne.
C it l d l h l i (2)
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 112/131
Congenital adrenal hyperplasia (2):
!
21-hydroxylase deficiency The most frequent syndrome (1:5000-1:15000 of newborn; 95% cases ofcongenital adrenal hyperplasia ). High 17-OH progesterone plasmaconcentration
! 11-hydroxylase deficiency
High 11-Deoxycorticosterone (DOC) and 11-Deoxycortisol plasmaconcentration
! 17-hydroxylase deficiency
Low plasma cortisol, estrogens and androgens concentrations, high 11-Deoxycorticosterone (DOC) (mineralocorticoid) plasma concentration.
!
hydroxylase 3-steroid or 5,4 Isomerase deficiency Low plasma cortisol, estrogens and androgens concentrations, high 17-OH
pregnenolone and dehydroepiandrosterone (DHEA) plasma concentration.
Review of congenital adrenal hyperplasia
syndromes caused by various defects in the
i h f id h
Cholesterol
StAR
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 113/131
Corticosterone (ZF/ZR) !
Aldosterone (ZG) !
Dehydroepiandrosterone(DHEA) ! 17"-OH pregnenolone
17 -hydroxylase
11
-Hydroxylase
Cortisol
11-Deoxycorticosterone (DOC) !
17"-OH progesterone
21-Hydroxylase
11-Deoxycortisol
Progesterone
3
-OHSD/&
5,4 Isomerase salt loss + female: virilized; male: hypogonadal
composite pathway of steroid hormone
biosynthesis .
P-450scc ACTH
Pregnenolone
Cholesterol
salt loss/sexual infantilism
Aldosterone synthase
Hypertension/sexual
infantilism
17
-hydroxylase
ALDOSTERONE
CORTISOLCORTICOSTERONE
salt loss/virilization
hypertension/virilization
initial salt loss
Testosterone
(made in peripheral
tissues by reduction of
androstenedione) !
Androstenedione
Congenital adrenal hyperplasia: 17- hydroxylase deficiency
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 114/131
Female with primaryamenorrhea,disproportionately longlimbs relative to the trunk,
absent axillary and pubichair, infantile breast andgenitalia development, anabsent uterus, and anincomplete vagina.
Congenital adrenal hyperplasia: 17 hydroxylase deficiency
Review of congenital adrenal hyperplasia
syndromes caused by various defects in the
it th f t id h
Cholesterol
StARl l / l i f ili
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 115/131
Corticosterone (ZF/ZR) !
Aldosterone (ZG) !
Dehydroepiandrosterone(DHEA) ! 17"-OH pregnenolone
17 -hydroxylase
11
-Hydroxylase
Cortisol
11-Deoxycorticosterone (DOC) !
17"-OH progesterone
21-Hydroxylase
11-Deoxycortisol
Progesterone
3
-OHSD/&
5,4 Isomerase salt loss + female: virilized; male: hypogonadal
composite pathway of steroid hormone
biosynthesis .
P-450scc ACTH
Pregnenolone
Cholesterol
salt loss/sexual infantilism
Aldosterone synthase
Hypertension/sexual
infantilism
17
-hydroxylase
ALDOSTERONE
CORTISOLCORTICOSTERONE
salt loss/virilization
hypertension/virilization
initial salt loss
Testosterone
(made in peripheral
tissues by reduction of
androstenedione) !
Androstenedione
Summary of Laboratory Findings
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 116/131
Summary of Laboratory Findings
Cushing's
Syndrome
Cushing's
Disease
Conn's
Syndrome
Addison's
Disease
Na high high high low
K low low low high
glucose high high normal low
cortisol high high normal low
ACTH low high normal usuallyhigh
• Adrenal glands physiology
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 117/131
• Adrenal glands physiology,
•
Adrenal cortex diseases,
Cushing’s syndrome
Mineralocorticoid excess
Adrenal insufficiencyCongenital adrenal hyperplasia
• Adrenal medulla diseases, Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 118/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 119/131
Major hormones of adrenal
medulla:
Catecholamines:
! norepinephrine,
!
epinephrine,
! dopamine.
Ph h
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 120/131
Pheochromocytoma:
- Uncommon but importanttumour of chromaffin cells.
- Occurs most commonly inadrenal gland (90%), but canbe found in any sympatheticganglion. Bilateral or multiple
tumours in 5-10%. 10% ofpheochromocytoma aremalignant.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 121/131
Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 122/131
Note the grey-tan colour of the tumour compared to the yellowcortex stretched around it and a small remnant of remaining adrenal
at the lower right. This patient had episodic hypertension.
Pheochromocytoma
Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 123/131
chromaffin reaction
(dichromate fixation)
eoc o ocyto a
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 124/131
Pheochromocytoma:
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 125/131
Pheochromocytoma:
Diagnosis:1) Clinical manifestations depend upon catecholamines
oversecretion. Diagnosis is suggested by paroxysmalnature of symptoms.
2) High urinary vanillylmandelic acid (VMA),metanephrine, normetanephrine and free catecholaminesexcretion rate. Hyperglycaemia.
3) Anatomic localization: ultrasonography, MRI orcomputed tomography of adrenal glands, isotope scan
technique with131
I iodobenzylguanidine.
Pheochromocytoma
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 126/131
- noradrenaline (NA) , adrenaline (A),- methoxyamines: normetanephrine (NMN) and metanephrine (MN).
- VMA (vanilmandelic acid) !
Pheochromocytoma
Pheochromocytoma:
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 127/131
Pheochromocytoma:
Diagnosis:1) Clinical manifestations depend upon catecholamines
oversecretion. Diagnosis is suggested by paroxysmalnature of symptoms.
2) High urinary vanillylmandelic acid (VMA),metanephrine, normetanephrine and free catecholaminesexcretion rate. Hyperglycaemia.
3) Anatomic localization: ultrasonography, MRI orcomputed tomography of adrenal glands, isotope scan
technique with131
I iodobenzylguanidine.
Pheochromocytoma:
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 128/131
y
computed tomography ofadrenal glands,
MRI ofadrenal glands,
Pheochromocytoma:
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 129/131
isotope scan technique with 131I iodobenzylguanidine.
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 130/131
7/26/2019 1. Endocrinology Part 1
http://slidepdf.com/reader/full/1-endocrinology-part-1 131/131